Get started
Author

Liam King

Observed names: King, Liam, King, Liam D., King, Liam Denson, L.B. King, Liam B King, Liam B. King, Liam D. King
Institution: Griffith University
ORCID: 0000-0002-6816-3784
Observed ORCID: 0000-0002-6816-3784
OpenAlex ID: A5062212625
Crystal structure of the Lassa virus nucleoprotein–RNA complex reveals a gating mechanism for RNA binding
2011 · Kathryn M. Hastie, Tong Liu, et al. · Proceedings of the National Academy of Sciences · 140
The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding
2018 · Liam B. King, Marnie L. Fusco, et al. · Cell Host & Microbe · 67
Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope
2018 · Brandyn R. West, Crystal L. Moyer, et al. · mBio · 45
Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation
2020 · Stephen J. Ralph, Andrew Weissenberger, et al. · Expert Opinion on Investigational Drugs · 33
PDF
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
2019 · Liam B. King, Brandyn R. West, et al. · Nature Communications · 31
PDF
The structural basis for filovirus neutralization by monoclonal antibodies
2018 · Liam B King, Brandyn R West, et al. · Current Opinion in Immunology · 28
Achieving cross-reactivity with pan-ebolavirus antibodies
2019 · Liam B King, Jacob C Milligan, et al. · Current Opinion in Virology · 25
Drivers of Radioresistance in Prostate Cancer
2022 · Liam King, Nijole Bernaitis, et al. · Journal of Clinical Medicine · 24
PDF
Comparison of oral vs. combined topical/intravenous/oral tranexamic acid in the prevention of blood loss in total knee arthroplasty: A randomised clinical trial
2019 · Liam King, Raymond Randle, et al. · Orthopaedics & Traumatology Surgery & Research · 23
PDF
Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study
2019 · Liam King, David Christie, et al. · Prostate International · 13
PDF
Quinazoline alpha-adrenoreceptor blockers as an adjunct cancer treatment: From bench to bedside
2020 · Liam King, David Christie, et al. · European Journal of Pharmacology · 11
The COX-2 inhibitor NS398 selectively sensitizes hypoxic HeLa cells to ionising radiation by mechanisms both dependent and independent of COX-2
2020 · Shailendra Anoopkumar-Dukie, Tom Conere, et al. · Prostaglandins & Other Lipid Mediators · 10
Trimethoprim‐sulfamethoxazole as Pneumocystis jiroveci pneumonia prevention in patients undergoing methotrexate therapy for hematological malignancies: A review of the literature
2020 · Liam D. King, Hanlon Sia, et al. · Hematological Oncology · 3
A Feasibility Study of the Repurposing of Prazosin to Improve Treatment Outcomes in Men Receiving Radiotherapy for Prostate Cancer (MiniRaP‐00)
2026 · Liam D. King, David Christie, et al. · The Prostate
Development and implementation of a pharmacy introductory cancer care program: Impacts on employee knowledge, engagement and retention
2025 · Liam King, Anastasia Peripetsakis, et al. · Journal of Oncology Pharmacy Practice
PDF
Administration orale ou combinée (orale et locale) d’acide tranexamique pour la prévention des pertes sanguines dans l’arthroplastie totale de genou : une étude clinique randomisée
2019 · Liam King, Raymond Randle, et al. · Revue de Chirurgie Orthopédique et Traumatologique
COX-2 selective inhibitors as an adjunct to radiotherapy
2018 · King, Liam Denson · Griffith Research Online
PDF
Structure of BDBV GPcl in complex with the pan-ebolavirus mAb ADI-15878
2018 · L.B. King, B.R. West, et al. · Worldwide Protein Data Bank
Works count: 20
Citation count: 453
H-index: 11
I10-index: 12
Year
Topic
Type